Regulation of TGF-β1-induced connective tissue growth factor expression in airway smooth muscle cells
- Publication Type:
- Journal Article
- Citation:
- American Journal of Physiology - Lung Cellular and Molecular Physiology, 2005, 288 (1 32-1)
- Issue Date:
- 2005-01-01
Closed Access
| Filename | Description | Size | |||
|---|---|---|---|---|---|
 | 2013000346OK.pdf | 317.39 kB |
Copyright Clearance Process
- Recently Added
- In Progress
- Closed Access
This item is closed access and not available.
Transforming growth factor (TGF)-β may play an important role in airway remodeling, and the fibrogenic effect of TGF-β may be mediated through connective tissue growth factor (CTGF) release. We investigated the role of MAPKs and phosphatidylinositol 3-kinase (PI3K) and the effects of inflammatory cytokines on TGF-β-induced CTGF expression in human airway smooth muscle cells (ASMC). We examined whether Smad signal was involved in the regulatory mechanisms. TGF-β1 induced a time- and concentration-dependent expression of CTGF gene and protein as analyzed by real-time RT-PCR and Western blot. Inhibition of ERK and c-jun NH2-terminal kinase (JNK), but not of p38 MAPK and PI3K, blocked the effect of TGF-β1 on CTGF mRNA and protein expression and on Smad2/3 phosphorylation. T helper lymphocyte 2-derived cytokines, IL-4 and IL-13, attenuated TGF-β1-stimulated mRNA and protein expression of CTGF and inhibited TGF-β1-stimulated ERK1/2 and Smad2/3 activation in ASMC. The proinflammatory cytokines tumor necrosis factor-α and IL-1β reduced TGF-β1-stimulated mRNA expression of CTGF but did not inhibit TGF-β-induced Smad2/3 phosphorylation. TGF-β1-stimulated CTGF expression is mediated by mechanisms involving ERK and JNK pathways and is downregulated by IL-4 and IL-13 through modulation of Smad and ERK signals.
Please use this identifier to cite or link to this item: